Morgan Stanley
BLPH

Morgan Stanley’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History

Morgan Stanley’s Portfolio BLPH Stock Details BLPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-33
Closed -$13 – 8077
2023
Q3 		$13 Hold
33
– – ﹤0.01% 7553
2023
Q2 		$23 Sell
33
-901,434
-100% -$5.81M ﹤0.01% 7581
2023
Q1 		$7.11M Buy
901,467
+899,990
+60,934% +$3.13M ﹤0.01% 3461
2022
Q4 		$1.33K Buy
1,477
+7
+0.5% +$7 ﹤0.01% 7431
2022
Q3 		$2K Sell
1,470
-3
-0.2% -$4 ﹤0.01% 7524
2022
Q2 		$2K Sell
1,473
-722
-33% -$965 ﹤0.01% 7647
2022
Q1 		$5K Sell
2,195
-3,292
-60% -$7.84K ﹤0.01% 7616
2021
Q4 		$17K Buy
5,487
+3,664
+201% +$12.2K ﹤0.01% 7294
2021
Q3 		$7K Sell
1,823
-215
-11% -$896 ﹤0.01% 7436
2021
Q2 		$9K Buy
2,038
+1,848
+973% +$8.29K ﹤0.01% 7289
2021
Q1 		$1K Sell
190
-5,035
-96% -$35.1K ﹤0.01% 7465
2020
Q4 		$34K Buy
5,225
+2,797
+115% +$22.9K ﹤0.01% 6281
2020
Q3 		$25K Sell
2,428
-670
-22% -$7.88K ﹤0.01% 5987
2020
Q2 		$39K Buy
3,098
+465
+18% +$6.51K ﹤0.01% 5766
2020
Q1 		$29K Buy
2,633
+2,600
+7,879% +$17.4K ﹤0.01% 5684
2019
Q4 		$0 Hold
33
– – ﹤0.01% 6881
2019
Q3 		$0 Sell
33
-51
-61% -$465 ﹤0.01% 6879
2019
Q2 		$0 Buy
84
+51
+155% +$489 ﹤0.01% 6858
2019
Q1 		$0 Hold
33
– – ﹤0.01% 6806
2018
Q4 		$0 Hold
33
– – ﹤0.01% 6834
2018
Q3 		$1K Sell
33
-206
-86% -$4.89K ﹤0.01% 6685
2018
Q2 		$9K Buy
239
+206
+624% +$7.13K ﹤0.01% 6339
2018
Q1 		$1K Hold
33
– – ﹤0.01% 6570
2017
Q4 		$1K Hold
33
– – ﹤0.01% 6530
2017
Q3 		$1K Hold
33
– – ﹤0.01% 6490
2017
Q2 		$1K Hold
33
– – ﹤0.01% 6544
2017
Q1 		$1K Hold
33
– – ﹤0.01% 6530
2016
Q4 		$0 Hold
33
– – ﹤0.01% 6608
2016
Q3 		$1K Hold
33
– – ﹤0.01% 6459
2016
Q2 		$1K Hold
33
– – ﹤0.01% 6465
2016
Q1 		$1K Hold
33
– – ﹤0.01% 6505
2015
Q4 		$1K Sell
33
-1,192
-97% -$57.7K ﹤0.01% 6595
2015
Q3 		$95K Sell
1,225
-1,321
-52% -$102K ﹤0.01% 5447
2015
Q2 		$303K Buy
2,546
+1,137
+81% +$155K ﹤0.01% 5021
2015
Q1 		$194K Buy
+1,409
New +$219K ﹤0.01% 5225

Other funds holding BLPH

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Morgan Stanley's BLPH Position: Q4 2023 in Review

Morgan Stanley sold out of Bellerophon Therapeutics, Inc. (BLPH) in Q4 2023, closing a stake of 33 shares — an estimated $13 sold.

Morgan Stanley first reported a position in BLPH in Q1 2015 and held it in 35 quarters. The position peaked at $7.11M in Q1 2023. 2 funds tracked by Wall St. Rank hold BLPH as of Q4 2023.

  • Morgan Stanley reported no remaining Bellerophon Therapeutics, Inc. position as of Q4 2023 after selling out during the quarter.
  • Morgan Stanley sold 33 Bellerophon Therapeutics, Inc. shares in Q4 2023, an estimated $13.
  • Morgan Stanley first reported a position in Bellerophon Therapeutics, Inc. in Q1 2015 and held it in 35 quarters.
  • Morgan Stanley's Bellerophon Therapeutics, Inc. position peaked at $7.11M in Q1 2023.
  • 2 funds tracked by Wall St. Rank held Bellerophon Therapeutics, Inc. as of Q4 2023.

Based on Morgan Stanley's 13F filing for Q4 2023, filed 13 Feb 2024.